Medreich Limited — Flucloxacillin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Flucloxacillin · $16.9M export value · DGFT Verified
Medreich Limited is the #1 Indian exporter of Flucloxacillin with $16.9M in export value and 337 verified shipments. Medreich Limited holds a 43.4% market share in Flucloxacillin exports across 8 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Flucloxacillin Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Flucloxacillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $5.7M | 157 | 48.5% |
| AUSTRALIA | $2.9M | 73 | 24.4% |
| NETHERLANDS | $2.5M | 84 | 21.3% |
| SOUTH AFRICA | $469.4K | 17 | 4.0% |
| NEW ZEALAND | $100.0K | 2 | 0.9% |
| BENIN | $75.1K | 2 | 0.6% |
| GHANA | $27.3K | 1 | 0.2% |
| DENMARK | $9.3K | 1 | 0.1% |
Medreich Limited exports Flucloxacillin to 8 countries. The largest destination is UNITED KINGDOM accounting for 48.5% of Medreich Limited's Flucloxacillin shipments, followed by AUSTRALIA (24.4%) and NETHERLANDS (21.3%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Flucloxacillin from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDREICH PLC | UNITED KINGDOM | $5.7M | 157 |
| MYLAN AUSTRALIA PTY LIMITED | AUSTRALIA | $2.9M | 73 |
| MYLAN IRELAND LTD | NETHERLANDS | $1.2M | 48 |
| MYLAN B.V | NETHERLANDS | $626.3K | 21 |
| MYLAN BV | NETHERLANDS | $350.0K | 7 |
| OETHMAAN BIOSIMS PTY LTD | SOUTH AFRICA | $272.1K | 8 |
| MYLAN B V ALLOGA NETHERLANDS BVDE KEMPKENS | NETHERLANDS | $257.1K | 6 |
| SANDOZ SA (PTY) LTD | SOUTH AFRICA | $120.8K | 4 |
| MYLAN B V | NETHERLANDS | $100.0K | 2 |
| VIATRIS NEW ZEALAND | NEW ZEALAND | $100.0K | 2 |
Medreich Limited supplies Flucloxacillin to 16 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by MYLAN AUSTRALIA PTY LIMITED (AUSTRALIA) and MYLAN IRELAND LTD (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Flucloxacillin Export Value and How Much Does Medreich Limited Contribute?
India exported $30.0M worth of Flucloxacillin through 1,146 shipments from 123 suppliers to 44 countries, serving 198 buyers globally. Medreich Limited contributes $16.9M to this total, accounting for 43.4% of India's Flucloxacillin exports. Medreich Limited ships Flucloxacillin to 8 countries through 16 buyers.
What Is the Average Shipment Value for Medreich Limited's Flucloxacillin Exports?
Medreich Limited's average Flucloxacillin shipment value is $50.0K per consignment, based on 337 shipments totaling $16.9M. The largest destination is UNITED KINGDOM (48.5% of Medreich Limited's Flucloxacillin exports).
How Does Medreich Limited Compare to Other Indian Flucloxacillin Exporters?
Medreich Limited ranks #1 among 123 Indian Flucloxacillin exporters with a 43.4% market share. The top 3 exporters are MEDREICH LIMITED ($16.9M), MICRO LABS LIMITED ($4.0M), AUROBINDO PHARMA LTD ($1.7M). Medreich Limited processed 337 shipments to 8 destination countries.
What Flucloxacillin Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUCLOXACILLIN 500MG CAPSULES BP 2X14S | $569.8K | 14 |
| FLUCLOXACILLIN 500MG CAPSULES BP 2X14 | $406.8K | 10 |
| FLUCLOXACILLIN CAPSULES BP 500MG 2X14S | $374.7K | 10 |
| FLUCLOXACILLIN CAPSULES 500MG (STAPHLEX | $300.0K | 6 |
| FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:30S QTY:12860 | $300.0K | 6 |
| FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:75S QTY:5154 | $300.0K | 6 |
| FLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $250.0K | 5 |
| FLUCLOXACILLIN 500MG CAPSULES BP (PACK S | $200.0K | 4 |
| FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:21S QTY:9223 | $174.7K | 6 |
| FLUCLOXACILLIN CAPSULES BP 500MG 2X14 | $174.2K | 4 |
Medreich Limited exports 171 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUCLOXACILLIN 500MG CAPSULES BP 2X14S with 14 shipments worth $569.8K.
Regulatory Requirements: Exporting Flucloxacillin to Key Markets
What Medreich Limited must comply with to export Flucloxacillin to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medreich Limited Compare to Nearest Flucloxacillin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MEDREICH LIMITED ★ | $16.9M | 337 | 8 | $50.0K |
| 2 | MICRO LABS LIMITED | $4.0M | 81 | 2 | $50.0K |
| 5 | AUROBINDO PHARMA LTD | $1.7M | 43 | 1 | $39.3K |
Medreich Limited ranks #1 among 123 Indian Flucloxacillin exporters. Average shipment value of $50.0K compared to the market average of $243.5K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Flucloxacillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 140 | 12.2% |
| BANGALORE ICD (INWFD6) | 107 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 8.7% |
| JNPT | 76 | 6.6% |
| BANGALORE ACC (INBLR4) | 69 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 55 | 4.8% |
| SAHAR AIR | 50 | 4.4% |
| BANGALORE AIR | 36 | 3.1% |
What Other Advanced Antibiotics Products Does Medreich Limited Export?
Medreich Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medreich Limited's Flucloxacillin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Flucloxacillin, top products include Amoxicillin, Potassium, Rosuvastatin, Atorvastatin, Ezetimibe. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Flucloxacillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 337 individual customs records matching Medreich Limited exporting Flucloxacillin, covering 171 formulations to 8 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 198+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Flucloxacillin Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Flucloxacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Flucloxacillin Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Flucloxacillin. For current shipment-level data, contact TransData Nexus.